Items without sitelinks
Showing below up to 50 results in range #541 to #590.
- secondary hyperparathyroidism (Q22016)
- secondary hyperparathyroidism of renal origin (Q22015)
- rare genetic parathyroid disease and phosphocalcic metabolism disorder (Q22014)
- rare genetic bone disease (Q22013)
- rare genetic bone development disorder (Q22012)
- primary bone dysplasia (Q22011)
- primary bone dysplasia with defective bone mineralization (Q22010)
- rare parathyroid disease and phosphocalcic metabolism anomaly (Q22009)
- disorders of vitamin D metabolism (Q22008)
- vitamin D deficiency (Q22007)
- metabolic bone disease (Q22006)
- (23S)-23,25-dihydroxycalciol (Q22005)
- 25-hydroxycholecalciferol-23-hydroxylase activity (Q22004)
- vasoconstriction (Q22003)
- vasoconstrictor agents (Q22002)
- calcium channel agonists (Q22001)
- autoimmune skin disease (Q22000)
- psoriasis (Q21999)
- antipsoriatic (Q21998)
- hyperparathyroidism (Q21997)
- vitamin D 23-hydroxylase activity (Q21996)
- 1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activity (Q21995)
- calcitriol binding (Q21994)
- calcidiol 1-monooxygenase activity (Q21992)
- calcidiol binding (Q21991)
- swelling (Q21989)
- flushing (Q21988)
- erythema (Q21987)
- pus (Q21986)
- suppuration (Q21985)
- abscess (Q21984)
- large intestine (Q21983)
- colonic disease (Q21982)
- colitis (Q21981)
- Crohn's colitis (Q21980)
- genetic epidermal disorder (Q21979)
- stratified epithelium (Q21978)
- squamous epithelium (Q21977)
- stratified squamous epithelium (Q21976)
- keratinized stratified squamous epithelium (Q21975)
- epidermis (Q21974)
- epidermal disease (Q21973)
- other epidermal disorder (Q21972)
- genodermatosis (Q21971)
- gland of epidermis (Q21970)
- holocrine (Q21969)
- sebaceous gland (Q21968)
- hair diseases (Q21967)
- sebaceous gland disease (Q21966)
- comedo (Q21965)